18094-16355 - Proton Therapy for Head and Neck Cancer

---

ONLINEProton Therapy Series

Monday, April 4, 2022, 12:00 AM - Tuesday, April 4, 2023, 11:59 PM


AMA PRA Category 1 Credits™ (2.50 hours), Non-Physician Attendance (2.50 hours)

This activity will cover the major aspects of operating a proton therapy treatment program.

1. Utilize the information presented to better prepare for proton therapy treatments, thus improving patient outcomes.
2. Incorporate knowledge on the responsibilities of dosimetrists, physicists and nurses in the treatment of proton therapy and the importance of their roles to provide optimal patient care.
3. Apply the knowledge of treatment planning and operations to perform proton therapy in respective centers/locations.
4. Gain a greater appreciation and perspective of the steps and personnel needed to perform quality proton therapy.

The content is no longer available for viewing or eligible for CE credit.

 

This activity is a recording of the Live Conference "International Proton Therapy Training" and will feature content presented by physicians, physicists, researchers and dosimetrists. These modules will cover the major aspects of operating a proton therapy treatment program.

Registration Fee: $75.00

For any questions, please contact Angie Castillo via email: [email protected]

Activity Completion Instructions:  Learners must complete a pre- and post-test for each module in chronological order. Upon completion of the final module post-test, the learner must procced to the activity evaluation (MyCE > Evaluations) in order to receive CE credit.  

 

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

No commercial support provided.